MedPath
TGA Approval

TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (156262)

156262

TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

October 28, 2008

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/1be3d27447458c1daf26b0eef9af246a.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b852067bb5fb02b18dcf5b097421f32e.pdf

Active Ingredients

fexofenadine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (156262) - TGA 批准文号 | MedPath